Andere Sprachen AcouSort AB

Aktien

A2DJ2K

SE0009189608

ACOU

Verzögert Nasdaq Stockholm Andere Börsenplätze 14:40:31 20.05.2024			% 5 Tage	% 1. Jan.
10.1 ^SEK	-1.46%		-7.34%	-35.05%

02.05.	AcouSort AB (publ) präsentiert zwei Poster, die den Wert der akustofluidischen Probenvorbereitung hervorheben	CI
29.04.	AcouSort AB (publ) und GenSensor SAS arbeiten zusammen, um die Kultivierung in Bioreaktoren zu verbessern	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

AcouSort will exhibit and present at CYTO 2024 – demonstrating the benefits of acoustic sample preparation for flow cytometry applications	02.05.
AcouSort AB to Present Two Posters Highlighting the Value of Acoustofluidics Sample Preparation	02.05.
Communiqué from the annual general meeting of AcouSort AB (publ)	30.04.
AcouSort and Gensensor enter collaboration aiming at improving bioreactor culturing	29.04.
AcouSort AB and GenSensor SAS Enters Collaboration Aiming At Improving Bioreactor Culturing	29.04.
AcouWash placed at two potential OEM partners	26.04.
AcouSort Initiates Two AcouWash Lease Collaborations with Potential OEM Partners	26.04.
Increased interest for AcouTrap EV isolation for nano flow cytometry applications	04.04.
AcouSort restructures its North American sales operation	03.04.
AcouSort AB Annual report 2023	02.04.
AcouSort AB Reports Earnings Results for the Full Year Ended December 31, 2023	02.04.
Shareholder interview with AcouSort’s CEO Torsten Freltoft and Commercial Director Agnes Michanek	13.03.
Year end report for AcouSort AB 1 January - 31 December 2023	28.02.
Significant technical progress in the AcouSome project – two novel patent applications filed	31.01.
AcouSort extends collaboration with leading cell therapy company into a third project phase	18.01.
AcouSort attends Advanced Therapies Week to extend its cell therapy network	16.01.
AcouSort : The board of directors resolves to repurchase warrants series 2020/2023	19.12.
AcouSort's rights issue is registered - conversion of BTU into shares and warrants	12.12.
FDA approval paves the way for AcouSort's first OEM commercialization within critical care diagnostics	11.12.
AcouSort : rights issue fully subscribed	05.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen AcouSort AB

Aktien

A2DJ2K

SE0009189608

ACOU

Andere Sprachen

Filter